Recent news on Ganite

Genta Incorporated to Present Multiple Abstracts at the Annual ...  -  25 May 2007
Earthtimes.orgThe lead drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for treatment

Genta Announces Closing of Common Stock Offering  -  Apr 4, 2007
Drug Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Genta and IDIS Announce Global Ex-US Agreement for Named Patient ...  -  27 Mar 2007
Drug Newswire (press release),Ganite is approved and marketed by Genta in the US for treatment of cancer-related hypercalcemia that is resistant to hydration. Early Phase 2 studies using

Genta Announces Closing of Common Stock Offering  -  Mar 15, 2007
PR Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Genta Closes Stock Offering  -  Mar 15, 2007
Forbes,The funds will help support named-patient distribution sales of cancer drugs Ganite and Genasense, the company said. Named-patient distribution refers to

Genta Closes 30 Mln Shares Of Common Stock Offering - Quick Facts  -  Mar 15, 2007
Trading Markets,...support general corporate activities, including product sales from the recently announced named-patient distribution programs for Ganite and Genasense.

Genta enters compassionate use agreement with IDIS  -  Mar 7, 2007
Pharmaceutical Business ReviewGenta Incorporated has said that IDIS will distribute two of its oncology products, Ganite and Genasense Injection, on a named patient and compassionate use

Market Report -- In Play (GNTA)  -  Mar 7, 2007
MSN MoneyGenta and IDIS announce global ex-US agreement for named patient/compassionate use distribution of Ganite and Genasense Co and IDIS announce the signing of

Genta Inks Special Deal With IDIS  -  Mar 7, 2007
Forbes,Drug developer Genta Inc. said Wednesday it inked a distribution agreement with UK-based IDIS Ltd. for its Ganite and Genasense drugs,

Epiphany's Series A Adds $36M For Infectious Disease Pipeline  -  Mar 15, 2007
BioWorld Online,Proceeds are expected to support general corporate activities, including product sales from the named-patient distribution programs for Ganite (gallium

Genta Incorporated Announces Fourth Quarter and Year End 2006 ...  -  Feb 13, 2007
Insurance News Net,The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Phase 2 Results Of Genasense(R) Plus Chemotherapy In Advanced ...  -  Feb 24, 2007
Medical News Today (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Q4 2006 Genta Earnings Conference Call - Final  -  Feb 20, 2007
Insurance News Net,We're also focused on developing an oral formulation of Ganite in order to expand its use into other bone-losing diseases, and we believe we're making

Genta Incorporated Announces Fourth Quarter and Year End 2006 ...  -  Feb 15, 2007
Drug Newswire (press release),...with Emisphere Technologies, Inc. on the development of an oral formulation of its currently marketed product, Ganite(R) (gallium nitrate injection).

BGCGN wrestlers strong at States  -  Feb 15, 2007
Nashua Telegraph (subscription),Fairgrounds grapplers Matt Glastetter, Rich Gamez and Gustavy Gamez also wreslted in the Ganite Class. In the Slate Class, BGCGN’s Pennichuck Middle School

Genta Slashes More Than a Third of its Workforce  -  Dec 20, 2006
Business New Jersey (subscription),Genta is testing another drug, Ganite, for non-Hodgkin’s lymphoma, in a phase II clinical trial. In early afternoon trading, Genta stock changed hands at

Genta Restructures Operations to Focus on Future Initiatives  -  Dec 20, 2006
Drug Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Genta Restructures Operations to Focus on Future Initiatives  -  Dec 20, 2006
Yahoo! News (press release)The leading drug in Genta's small molecule program is Ganite® (gallium nitrate injection), which the Company is exclusively marketing in the US for treatment ...

Genta Slashes More Than a Third of its Workforce  -  Dec 20, 2006
Business New Jersey (subscription),...drug development.�. Genta is testing another drug, Ganite, for non-Hodgkin’s lymphoma, in a phase II clinical trial. In early ...

Genta Receives a Heavy Blow  -  Dec 15, 2006
Business New Jersey (subscription),2004, Sanofi ended the partnership. Genta’s other drug, Ganite for non-Hodgkin’s lymphoma, is in a phase II clinical trials.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional